482 results on '"Diabetes therapy -- Reports -- Forecasts and trends"'
Search Results
2. Research and Markets Issues Report: Generic Injectables Global Strategic Business 2024-2030
3. Research and Markets Offers Report: Global Medical Device Contract Manufacturing Industry 2024-2029
4. Research and Markets Offers Report: Global Medical Device Contract Manufacturing Industry 2024-2029
5. Global Point of Care Glucose Testing Market Size|Share Worth USD 5,455.3 Million by 2033 at a 4.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
6. United States Diabetes Device Market Forecast Report and Company Analysis 2024-2032 Featuring BD, Roche, Medtronic, Insulet, Abbott, Dexcom, Tandem Diabetes Care, Ypsomed Novo Nordisk, Eli Lilly
7. Global Dry Eye Disease Treatment Market Projected to Cross USD 9 Billion by 2030 | DelveInsight
8. Global Pediatric Drugs Market is Predicted to Resister Growth at a CAGR of ~5% by 2030 | DelveInsight
9. Diabetes Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
10. $107+ Bn Diabetes Drug Market by Drug class, Diabetes types, Route of Administration, Distribution Channels, Region and Company Analysis - Global Forecast to 2032
11. Research and Markets Releases Report: Generic Injectables Global Strategic Business 2024-2030
12. Type 2 Diabetes Treatment Market Size is expected to grow with a significant CAGR during the study period (2020-2034)
13. US Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report 2024-2030 Featuring ConvaTec, 3M, Coloplast, Smith & Nephew, B Braun Melsungen, Medline, Molnlycke Health Care, Medtronic
14. Global Short-Acting Insulin Market is Expected to Cross ~USD 9 Billion by 2030 | DelveInsight
15. Southeast Asia Diabetes Devices Market Analysis Report 2024-2030: emERGE Program to Enhance Diabetes Education Across 11 Countries
16. U.S. Complementary and Alternative Medicine Size & Trends Analysis Report 2024: Market to Reach $124.2 Billion by 2030, Growing at a CAGR of 23.9%
17. Global GLP-1 Receptor Agonist Market Analysis Report 2024-2030
18. Diabetes Pen Market Insights, Competitive Landscape and Market Forecast 2024-2030
19. Research and Markets Adds Report: Global Glucagon-like Peptide 1 (GLP-1) Market
20. $6.121 Bn Retail Clinics Market - Global Forecasts from 2024 to 2029 with Walgreen, Walmart, and Rite Aid Corp Spearheading Growth
21. Prediabetes Market is Projected to Boost at a Moderate Growth Rate by 2034, Predicts DelveInsight | Key Companies - Novo Nordisk, Aphaia Pharma, HighTide Biopharma Pty Ltd, Eli Lilly and Company, Corcept Therapeutics
22. Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity Market Analysis 2024 - The Use of GLP-1R Agonists is Expected to Quadruple in the Next 10 Years, at a CAGR of 14.9%
23. Global Medical Device Contract Manufacturing Industry Research 2024-2029: Increasing Consolidation of OEMs and Contract Manufacturers & Growing Interest of Private Equity Firms
24. Gestational Diabetes Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies and Patient based Forecast by DelveInsight | Antares Pharma, Eli Lilly, Sanofi, Novo Nordisk, Abbott
25. Comprehensive Market Analysis Reveals Significant Insights into the Insulin Pumps and Continuous Glucose Monitors Market Through 2033
26. Global Smart Insulin Pens Market 10 Year Forecast Report 2024-2034 - A USD 2.30 Billion Market by 2034 with a 10% CAGR During 2024-2034
27. Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
28. Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
29. Type 1 Diabetes Market: Latest Study by DelveInsight Forecasts Remarkable Growth During the Forecast Period (2023-32) | Amytrx, Anelixis, Arecor, AstraZeneca, Eli Lilly, Histogen, ImCyse, Kamada
30. Artificial Pancreas Device System Market: Revolutionizing Diabetes Management, Expected to Grow at a CAGR of 18.94% by Delveinsight | GE Healthcare; Philips; SunTech Medical, Omron Healthcare
31. Global Continuous Glucose Monitoring Devices Market Analysis Report 2024-2030, Featuring Dexcom, Abbott, Medtronic, Ypsomed, Senseonics Holdings, A. Menarini Diagnostics and Signos
32. Digital Diabetes Management Market to reach over USD 49.5 Bn by the year 2031 - Explained Details | Exclusive Study by InsightAce Analytic
33. Global Continuous Glucose Monitoring Devices Market Analysis Report 2024-2030, Featuring Dexcom, Abbott, Medtronic, Ypsomed, Senseonics Holdings, A. Menarini Diagnostics and Signos
34. Anesthesia Devices Market to Grow by USD 3.34 billion from 2022 to 2027; Ambu AS and B. Braun SE are some of the major market players -Technavio
35. Human Insulin Drugs Market In Brazil 2023-2028: Market Analysis, Drivers, Restraints, Opportunities, and Threats - 17000 + Technavio Reports
36. REMD-477 (Volagidemab) for Type 1 Diabetes Mellitus: Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032 - Focus on 7 Major Markets
37. LANTIDRA (Donislecel) Emerging Drug Insights and Market Forecasts, 2019-2032: A Novel Cellular Therapy Being Evaluated for Use in Brittle Type 1 Diabetes
38. Human Insulin Market Set to Soar Past USD 21.80 Billion by 2030 | Skyquest Technology
39. Human Insulin Market Set to Soar Past USD 21.80 Billion by 2030 | Skyquest Technology
40. Research and Markets Offers Report: Global Medical Device Contract Manufacturing Industry 2024-2029
41. Do we know diabetes well: keys to understanding and controlling it?
42. Research and Markets Adds Report: Global Diabetes Insulin Delivery Pen Market 2022
43. Research and Markets Adds Report: Insulin Market
44. Digital Diabetes Management Market Forecast Report 2023-2030, Featuring Key Players Medtronic, Abbott, Ascensia Diabetes Care, F. Hoffmann-La Roche, Bayer, LifeScan & Insulet
45. Digital Diabetes Management Market Forecast Report 2023-2030, Featuring Key Players Medtronic, Abbott, Ascensia Diabetes Care, F. Hoffmann-La Roche, Bayer, LifeScan & Insulet
46. Gestational Diabetes Market to witness growth by 2032, estimates DelveInsight | Antares Pharma, 3M, Eli Lilly, Sanofi, Novo Nordisk, Abbott, AstraZeneca, Novartis, Daiichi Sankyo, Boehringer Ingelheim
47. Diabetes Injection Pens Market is set to Reach US$ 15.19 billion at a CAGR of 7.3% from the forecast period 2023 to 2031 | Growth Plus Reports
48. Diabetes Injection Pens Market is set to Reach US$ 15.19 billion at a CAGR of 7.3% from the forecast period 2023 to 2031 | Growth Plus Reports
49. HbA1c Testing Market is set to Reach US$ 3.06 billion at a CAGR of 8.1% from the forecast period 2023 to 2031 | Growth Plus Reports
50. Diabetes Management Apps Market to Record an Exponential CAGR of 24.4% by 2031 - Exclusive Report by InsightAce Analytic
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.